“…( 3 ) Thus, the original rationale based on its osmotic effect that enables small volume resuscitation in hypovolemic shock ( 2 ) and decreases brain edema after traumatic brain injury ( 4 ) may be too simplistic. The results presented by Rios et al ( 1 ) add to previous demonstrations of benefit from HSS on several different aspects of inflammation and organ function in pre-clinical models of systemic inflammatory response syndrome (SIRS) and sepsis. ( 3 ) However, human trials have failed to provide convincing evidence of efficacy.…”